KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Short term Debt (2016 - 2025)

Astrazeneca has reported Short term Debt over the past 11 years, most recently at $3.1 billion for Q4 2025.

  • Quarterly results put Short term Debt at $3.1 billion for Q4 2025, up 32.82% from a year ago — trailing twelve months through Dec 2025 was $3.1 billion (up 32.82% YoY), and the annual figure for FY2025 was $3.1 billion, up 32.82%.
  • Short term Debt for Q4 2025 was $3.1 billion at Astrazeneca, up from $2.3 billion in the prior quarter.
  • Over the last five years, Short term Debt for AZN hit a ceiling of $5.3 billion in Q4 2022 and a floor of $1.7 billion in Q4 2021.
  • Median Short term Debt over the past 5 years was $3.1 billion (2025), compared with a mean of $3.5 billion.
  • Biggest five-year swings in Short term Debt: skyrocketed 220.12% in 2022 and later plummeted 54.44% in 2024.
  • Astrazeneca's Short term Debt stood at $1.7 billion in 2021, then skyrocketed by 220.12% to $5.3 billion in 2022, then decreased by 3.48% to $5.1 billion in 2023, then plummeted by 54.44% to $2.3 billion in 2024, then surged by 32.82% to $3.1 billion in 2025.
  • The last three reported values for Short term Debt were $3.1 billion (Q4 2025), $2.3 billion (Q4 2024), and $5.1 billion (Q4 2023) per Business Quant data.